Company intelligence / Profile preview

Onegevity Health

New York, New York, United Statescdn.onegevity.com ↗

Ownership: Private
Development stage: Commercial

Overview

Onegevity developed a multi-modal AI-driven platform integrating blood work, genetics/genomics, microbiome data and other clinical/lifestyle inputs to provide personalized recommendations for nutrition and wellness. Its first product was GutBio™, an at-home gut microbiome test with AI-based analysis. The company expanded into whole-genome sequencing and blood testing for broader wellness applications. No clinical trial results are reported as the company does not develop therapeutics but provides consumer diagnostics and recommendations.

Modalities: Non-pharmacological therapy (personalized lifestyle, nutrition, supplement recommendations)Device (at-home test kits)
Industry: Molecular Diagnostics

Partnerships

Indena (partnership for personalized botanical-based nutrition)

Beyond the preview

Go deeper on Onegevity Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onegevity Health.

Explore the full profile